Human Tissue Engineering Company Prellis Biologics Raises $8.7 Million Series A Round; Announces First Animal Transplant of Its 3D-Printed Tissue - Business Wire
Human Tissue Engineering Company Prellis Biologics Raises $8.7 Million Series A Round; Announces First Animal Transplant of Its 3D-Printed Tissue Business WirePrellis Biologics raises $8.7 million in round led by Khosla Ventures and announces progress in 3D holographic printing to create tissue and organs.